Last reviewed · How we verify
BAFFR-CAR T cells
At a glance
| Generic name | BAFFR-CAR T cells |
|---|---|
| Sponsor | PeproMene Bio, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BAFFR-CAR T cells CI brief — competitive landscape report
- BAFFR-CAR T cells updates RSS · CI watch RSS
- PeproMene Bio, Inc. portfolio CI